Stock vs Stock Comparison

Zoetis Inc. vs Eli Lilly and Company

LLY wins the Tale of the Tape 7–2.

ZTS$77.59
LLY$1078.78

🏆 Tale of the Tape

27
ZTSLLY
28.2%Profitability (Net Margin)31.7%
12.7xValuation (P/E)39.2x
21.4%Efficiency (ROIC)30.4%
6/9Health (Piotroski F)7/9
5.4Safety (Altman Z)7.8
2.3%Growth (Rev YoY)44.7%
-0.86Risk (Sharpe 1Y)0.61
3.64xBalance Sheet (D/E)3.24x
4.04%FCF Yield0.68%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.218
252-Day Correlation
0.116
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricZTSLLY
Market Cap$32.6B$985.4B
P/E Ratio12.7x39.2x
Forward P/E10.5x24.8x
P/B9.91x31.65x
Dividend Yield2.73%0.63%
Beta0.860.48

Quantitative Metrics

MetricZTSLLY
DCF Fair Value$130.31$296.11
DCF Upside+8.5%-68.2%
Piotroski F6/97/9
Altman Z5.437.84
Beneish M-2.44-1.91
FCF Yield4.04%0.68%
Net Debt/EBITDA1.7x1.1x
ROIC21.4%30.4%
WACC9.8%7.8%
ROIC – WACC11.6pp22.5pp
Gross Margin71.8%83.0%
Net Margin28.2%31.7%
Rev Growth YoY2.3%44.7%
Sharpe (1Y)-0.860.61
Max Drawdown 3Y-41.9%
FCF Payout Ratio39%90%

ZTS Price

Loading chart...

LLY Price

Loading chart...

ETF Exposure

ZTS found in:

MOAT1.32%
XPH1.22%
VOT1.03%
VHT0.82%
XLV0.63%
VO0.44%
DGRW0.30%
VIG0.22%
VYM0.21%
RSP0.21%
SCHV0.19%
IWF0.15%
VONG0.13%
SPYV0.12%
SPLG0.11%
ESGV0.10%
IVV0.09%
QUS0.09%
SCHX0.09%
VTV0.09%
SCHB0.09%
ITOT0.08%
VOO0.08%
VONE0.08%
VUG0.08%
URTH0.07%
VTI0.06%
ACWI0.06%
SPY0.05%
VT0.05%
SPTM0.05%
IWD0.04%
ONEO0.03%
VONV0.03%

LLY found in:

XLV15.40%
IYH13.72%
VHT12.15%
VIG3.33%
SCHG3.17%
QUAL2.92%
MGK2.82%
IWF2.66%
VONG2.42%
SPYG2.36%
VUG2.31%
IVW2.23%
QUS1.95%
XPH1.90%
ESGV1.48%
DGRW1.46%
IVV1.46%
SCHX1.34%
SPY1.29%
ITOT1.29%
SCHB1.25%
VFQY1.23%
VOO1.20%
SPTM1.20%
VTI1.14%
VONE1.14%
SPLG1.10%
ARKG1.04%
URTH0.99%
ACWI0.87%
VT0.66%
VFMO0.46%
RSP0.20%
ONEO0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ZTS vs LLY: Head-to-Head Analysis

Zoetis Inc. (ZTS) and Eli Lilly and Company (LLY) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, LLY leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ZTS generates a return on invested capital (ROIC) of 21.4% compared to LLY's 30.4%. This suggests LLY is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ZTS and LLY is 0.218, indicating low correlation, making them an effective diversification pair in a portfolio context.

ZTS appears in 34 ETFs tracked by SecuritiesDB, while LLY appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ZTS or LLY?

Our quantitative analysis compares ZTS and LLY across nine fundamental dimensions. LLY wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ZTS and LLY correlated?

The 252-day correlation between ZTS and LLY is 0.218. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.